The present invention is directed to certain piperidine compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.
本发明涉及某些
哌啶化合物,其可用作神经激肽1(NK-1)受体拮抗剂,并且是
缓激肽,特别是物质P的
抑制剂。本发明还涉及包含这些化合物作为活性成分的制药配方以及利用这些化合物及其配方治疗某些疾病,包括呕吐、尿失禁、抑郁症和焦虑症。